Abstract:
Thanks to the organization and improvement of diagnostic methods, new
methods of treatment, surgical techniques, significant progress has been
made in the treatment of acute purulent-destructive lung diseases (APDLD).
However, this problem remains relevant today. In recent years, there has
been an increase in the number of patients with severe and complicated
forms of AHDD [1]
As we know, according to studies [2,3,4] the percentage of development of
pulmonary-pleural complications in lung abscesses ranges from 30% to 70%,
and the incidence of gangrenous forms from 28% to 74%. Despite various
approaches to the treatment of AHDD, the results of complex treatment can
hardly be considered satisfactory. There is still a high mortality rate, which
ranges from 12.7% to 77.8% in various forms of purulent-necrotic process.
Management and treatment of patients with this pathology requires an
individual approach and a set of therapeutic measures.
